About

Exclusively Healthcare. Built for Growth.

Modern cleanroom manufacturing lab with glass walls, stainless workstations, monitors, and technicians in blurred motion.

1315 Capital is a private equity firm exclusively focused on investing in growth-stage healthcare companies.

We partner with commercial-stage companies across healthcare services, pharma/medtech products, pharma/medtech outsourcing, and health & wellness verticals.

Founded in 2014 by healthcare investment veterans Adele Oliva and Michael Koby, 1315 Capital was built on a simple premise: healthcare investing requires specialized expertise, and successful partnerships require genuine collaboration.

Since inception, we’ve remained committed to our core values of industry specialization, operational excellence, and authentic partnership with management teams.

What began as a vision to create a different kind of private equity firm has evolved into a proven platform that consistently delivers value for investors while making a meaningful impact on the healthcare industry.

$1B+

AUM

2014

Founded

34

Platform Investments

$500M+

Revenue Growth Across Portfolio

Modern laboratory bench with a microscope and neatly arranged glassware—test tubes, flasks, beakers, and graduated cylinders—in a bright, sterile lab with cabinets and instruments blurred in the blue-tinted background.

The 1315 Capital Advantage

Healthcare Focus Icon

Healthcare Specialization

Every aspect of our firm is built around healthcare specialization, allowing us to navigate complex industry dynamics to source, diligence, and create value for healthcare companies.

Healthcare Focus Icon

Growth Acceleration

We invest in companies with significant growth potential that can be realized through our investment and hands-on engagement, leveraging our operating team members and industry expertise.

Healthcare Focus Icon

Value-Added Partners

Trusted by management teams as true partners, we combine healthcare expertise with practical support to unlock growth.

Healthcare Focus Icon

Proprietary Deal Engine

The majority of our deals are proprietary in nature, generated through our dedicated business development team, decades of industry relationships, and proactive investment themes.